News
Showing 1–20 of 125 results
-
Press Releases
Coulter Partners places industrial biotech leader Thomas Durhuus as CEO of Kaffe Bueno
02 February 2026
-
Press Releases
Coulter Partners Places Industry Veteran Mark Rothera as CEO of TreeFrog Therapeutics
27 January 2026
-
Press Releases
Coulter Partners places Daniel Green as Chief Operating Officer at mOm Incubators
20 January 2026
-
Press Releases
Coulter Partners places seasoned financial leader David Hastings as CFO at Trevi Therapeutics
13 January 2026
-
Press Releases
Coulter Partners places Chief Executive Officer at Alethio Therapeutics
07 January 2026
-
Press Releases
Coulter Partners places Chief Scientific Officer at Slingshot Therapeutics
19 November 2025
-
Press Releases
Coulter Partners places R&D Senior Project Director at Vicore Pharma Holding
04 November 2025
-
Press Releases
Coulter Partners conducts successful CFO search for Tristel plc
22 October 2025
-
Placement News
Top hires for Q3-2025
21 October 2025
-
Press Releases
Coulter Partners places Gregory Reinaud as Chief Operating Officer of Proveca
14 October 2025
-
Press Releases
Coulter Partners places Managing Director of Parkinson’s UK
01 October 2025
-
Press Releases
Coulter Partners places CSO at Alltrna
18 September 2025
-
Press Releases
Coulter Partners places COO at Cell and Gene Therapy Catapult
10 September 2025
-
Press Releases
Coulter Partners successfully places Valerio Ferri as ExoLab Italia's new CEO
10 September 2025
-
Press Releases
Coulter Partners secures Dieter Weinand as Board Chair for AstriVax Therapeutics
02 September 2025
-
Placement News
Top hires for Q2-2025
22 July 2025
-
Press Releases
Coulter Partners places Non-executive Director at Australian life sciences company, QBiotics Group Ltd
15 July 2025
-
Press Releases
Coulter Partners continues partnership with iOnctura and places new Chief Financial Officer
10 July 2025
-
Press Releases
Coulter Partners secures Chief Scientific Officer for Biomia
08 July 2025
-
Press Releases
Coulter Partners successfully places three senior executives at Augustine Therapeutics
03 July 2025
